Neuropathic pain associated with Nav1.7 mutations. Clinical picture and treatment

被引:3
|
作者
Doppler, K. [1 ]
Sommer, C. [1 ]
机构
[1] Univ Klinikum Wurzburg, Neurol Klin & Poliklin, D-97080 Wurzburg, Germany
来源
NERVENARZT | 2013年 / 84卷 / 12期
关键词
Nav1.7; SCN9A mutation; Small fiber neuropathy; Erythromelalgia; polymorphism; SMALL-FIBER NEUROPATHY; CHANNEL ALPHA-SUBUNIT; FAMILIAL ERYTHROMELALGIA; SODIUM-CHANNELS; NA(V)1.7; SCN9A; DISORDER; POLYMORPHISM; ERYTHERMALGIA; SYMPTOMS;
D O I
10.1007/s00115-012-3621-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Voltage-gated sodium channels are essential for electrogenesis in excitable cells. The isoform Nav1.7 is primarily expressed in nociceptors. Mutations of the SCN9A gene, which codes for the alpha-subunit of Nav1.7, are the cause of primary erythromelalgia and paroxysmal extreme pain disorder, two rare neuropathic pain conditions. Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain. These findings not only contribute to the understanding of the pathophysiology of neuropathic pain but also offer targets for a more specific pain therapy.
引用
收藏
页码:1428 / +
页数:6
相关论文
共 50 条
  • [11] A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials
    Dormer, Anton
    Narayanan, Mahesh
    Schentag, Jerome
    Achinko, Daniel
    Norman, Elton
    Kerrigan, James
    Jay, Gary
    Heydorn, William
    JOURNAL OF PAIN RESEARCH, 2023, 16 : 1487 - 1498
  • [12] Sodium channels Nav1.7, Nav1.8 and pain; two distinct mechanisms for Nav1.7 null analgesia
    Iseppon, Federico
    Kanellopoulos, Alexandros H.
    Tian, Naxi
    Zhou, Jun
    Caan, Gozde
    Chiozzi, Riccardo
    Thalassinos, Konstantinos
    Cubuk, Cankut
    Lewis, Myles J.
    Cox, James J.
    Zhao, Jing
    Woods, Christopher G.
    Wood, John N.
    NEUROBIOLOGY OF PAIN, 2024, 16
  • [13] Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navβ4 peptide-mediated resurgent sodium currents
    Theile, Jonathan W.
    Jarecki, Brian W.
    Piekarz, Andrew D.
    Cummins, Theodore R.
    JOURNAL OF PHYSIOLOGY-LONDON, 2011, 589 (03): : 597 - 608
  • [14] Nav1.7 protein and mRNA expression in the dorsal root ganglia of rats with chronic neuropathic pain
    Liu, Chao
    Cao, Jing
    Ren, Xiuhua
    Zang, Weidong
    NEURAL REGENERATION RESEARCH, 2012, 7 (20) : 1540 - 1544
  • [15] Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain
    Niu, He-ling
    Liu, Ya-ni
    Xue, Deng-qi
    Dong, Li-ying
    Liu, Hui-jie
    Wang, Jing
    Zheng, Yi-lin
    Zou, An-ruo
    Shao, Li-ming
    Wang, KeWei
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (08) : 1235 - 1247
  • [16] Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain
    Bankar, Girish
    Goodchild, Samuel J.
    Howard, Sarah
    Nelkenbrecher, Karen
    Waldbrook, Matthew
    Dourado, Michelle
    Shuart, Noah G.
    Lin, Sophia
    Young, Clint
    Xie, Zhiwei
    Khakh, Kuldip
    Chang, Elaine
    Sojo, Luis E.
    Lindgren, Andrea
    Chowdhury, Sultan
    Decker, Shannon
    Grimwood, Michael
    Andrez, Jean-Christophe
    Dehnhardt, Christoph M.
    Pang, Jodie
    Chang, Jae H.
    Safina, Brian S.
    Sutherlin, Daniel P.
    Johnson, James P., Jr.
    Hackos, David H.
    Robinette, C. Lee
    Cohen, Charles J.
    CELL REPORTS, 2018, 24 (12): : 3133 - 3145
  • [17] Neuropathic pain in two-generation twins carrying the sodium channel Nav1.7 functional variant R1150W
    Harrer, Judith U.
    Uceyler, Nurcan
    Doppler, Kathrin
    Fischer, Tanya Z.
    Dib-Hajj, Sulayman D.
    Waxman, Stephen G.
    Sommer, Claudia
    PAIN, 2014, 155 (10) : 2199 - 2203
  • [18] Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7Differential activities of Nav1.7-targeting monoclonal antibodies
    Sangsu Bang
    Jiho Yoo
    Xingrui Gong
    Di Liu
    Qingjian Han
    Xin Luo
    Wonseok Chang
    Gang Chen
    Sang-Taek Im
    Yong Ho Kim
    Judith A. Strong
    Ma-Zhong Zhang
    Jun-Ming Zhang
    Seok-Yong Lee
    Ru-Rong Ji
    Neuroscience Bulletin, 2018, 34 : 22 - 41
  • [19] A Peripherally Acting Nav1.7 Sodium Channel Blocker Reverses Hyperalgesia and Allodynia on Rat Models of Inflammatory and Neuropathic Pain
    McGowan, Erin
    Hoyt, Scott B.
    Li, Xiaohua
    Lyons, Kathryn A.
    Abbadie, Catherine
    ANESTHESIA AND ANALGESIA, 2009, 109 (03): : 951 - 958
  • [20] No mutations in the voltage-gated NaV1.7 sodium channel α1 subunit gene SCN9A in familial complex regional pain syndrome
    de Rooij, A. M.
    Gosso, M. F.
    Alsina-Sanchis, E.
    Marinus, J.
    van Hilten, J. J.
    van den Maagdenberg, A. M. J. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (06) : 808 - 814